Dr. Sada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2002 Holcombe Blvd
Dept Of Hematology & Oncology Va 111 H
Houston, TX 77030Phone+1 713-794-7111Fax+1 713-794-7733
Education & Training
- Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- Baylor College of MedicineResidency, Internal Medicine, 2005 - 2008
- University of Rochester School of Medicine and DentistryClass of 2005
Certifications & Licensure
- TX State Medical License 2011 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Meclizine for Hepatocellular Carcinoma Start of enrollment: 2017 Oct 13
Publications & Presentations
PubMed
- A Multi-Institutional Natural Language Processing Pipeline to Extract Performance Status From Electronic Health Records.Arash Maghsoudi, Yvonne H Sada, Sara Nowakowski, Danielle Guffey, Huili Zhu
Cancer Control. 2024-09-02 - 2 citationsHarnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer.Gozde Cay, Yvonne H Sada, Mohammad Dehghan Rouzi, Md Moin Uddin Atique, Naima Rodriguez
Scientific Reports. 2024-01-31 - Study protocol: maintaining preventive care during public health emergencies through effective coordination.Sylvia J Hysong, Traber Davis Giardina, Jennifer Freytag, Richard SoRelle, Daniel R Murphy
Implementation Science Communications. 2023-11-27
Press Mentions
- Resilient Cancer Patient Grateful for Houston VAMarch 20th, 2023
- A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal CancerApril 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: